When should a non‑contrast head CT be obtained after intravenous alteplase administration for an acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Alteplase Cranial CT Timing

Obtain a follow-up non-contrast head CT or MRI at 24 hours after IV alteplase administration before starting any anticoagulants or antiplatelet agents. 1

Routine Post-Treatment Imaging

The American Heart Association/American Stroke Association guidelines establish a clear protocol for post-alteplase neuroimaging:

  • Perform routine follow-up CT or MRI scan at 24 hours after IV alteplase infusion before initiating anticoagulant or antiplatelet therapy 1
  • This 24-hour imaging serves to detect hemorrhagic transformation and assess infarct evolution before starting antithrombotic medications 1
  • The timing is standardized regardless of clinical course, provided the patient remains neurologically stable 1

Emergency Imaging Indications

If clinical deterioration occurs at any time during or after alteplase administration, obtain an emergent non-contrast head CT immediately—do not wait for the scheduled 24-hour scan. 1

Specific triggers requiring immediate CT imaging include:

  • Severe headache 1
  • Acute hypertension (systolic BP >180 mmHg or diastolic >105 mmHg despite treatment) 1
  • Nausea or vomiting 1
  • Worsening neurological examination (any decline in NIHSS or level of consciousness) 1

Management During Deterioration

  • Discontinue the alteplase infusion immediately if still running 1
  • Obtain emergent non-enhanced head CT to evaluate for symptomatic intracranial hemorrhage 1
  • If hemorrhage is confirmed, initiate reversal protocol with cryoprecipitate (10 units), tranexamic acid (1000 mg IV) or ε-aminocaproic acid (4-5 g loading dose), and obtain hematology and neurosurgery consultations 1, 2

Clinical Monitoring Schedule

The guidelines mandate intensive neurological surveillance that determines when imaging may be needed:

  • Every 15 minutes during and for 2 hours after IV alteplase infusion 1
  • Every 30 minutes for the subsequent 6 hours (hours 2-8) 1
  • Hourly from 8 to 24 hours after treatment 1

This frequent monitoring allows early detection of complications that would trigger emergency imaging before the routine 24-hour scan 1.

Rationale for 24-Hour Timing

The 24-hour timepoint balances several considerations:

  • Hemorrhagic transformation typically manifests within the first 24-36 hours after alteplase, with symptomatic intracranial hemorrhage rates of 2.4-6.4% across major trials 3, 4
  • Antiplatelet and anticoagulant therapy must be delayed until hemorrhage is excluded, as these agents would exacerbate any bleeding 1
  • The Canadian Stroke Best Practice guidelines similarly recommend maintaining blood pressure <180/105 mmHg for 24 hours after alteplase, aligning with the imaging timeframe 1

Common Pitfalls

  • Do not delay the 24-hour CT beyond this timeframe, as it gates initiation of secondary stroke prevention therapies 1
  • Do not obtain routine imaging earlier than 24 hours unless clinically indicated, as early ischemic changes may be difficult to interpret and do not change management in stable patients 1
  • Do not start antiplatelet or anticoagulant therapy before the 24-hour imaging is completed and reviewed, even if the patient appears clinically improved 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Emergency Craniotomy After Alteplase Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Ischemic Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

The New England journal of medicine, 2008

Related Questions

What is the time window for administering IV thrombolysis with alteplase (tissue plasminogen activator) in an adult patient with acute cerebellar stroke?
What is the next step for an elderly patient with symptoms of stroke lasting 90 minutes, negative computed tomography (CT) head, and hypertension (blood pressure 165/70)?
What is the most appropriate next step in managing a 76-year-old male with acute onset of focal neurological deficits, including slurred speech, left-sided motor deficits, and facial droop, with a history of hypertension and diabetes, and a non-contrast CT scan ruling out hemorrhagic stroke?
What is the immediate treatment for acute ischemic stroke?
What is the most appropriate next step in managing a 61-year-old female with stroke-like symptoms, large-vessel occlusion, and unresolved neurological deficits, 4 hours after her last known normal state, following intravenous (IV) alteplase administration?
What are the recommended treatment options for vaginismus after unsupervised pelvic‑floor exercises have failed?
What is the appropriate evaluation and management for a term newborn who has not passed meconium within the first 24 hours?
What is the recommended management for an adult with idiopathic focal cervical dystonia?
What are the therapeutic serum phenytoin concentrations and recommended loading and maintenance doses, and how should they be adjusted in patients with low albumin or renal impairment?
How should an infertile male with low luteinizing hormone, low follicle‑stimulating hormone, and low testosterone be evaluated and managed?
What is the formula for the cardiothoracic ratio on a chest X‑ray to assess cardiomegaly, and what are the normal cutoff values for posterior‑anterior and anterior‑posterior views?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.